| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5afb85619129f887952a8b5119230d5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de174b68e08cef0370c7ad1ae122ef30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93d2528036e11347d67abb7dd9502244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed061db575a89df0b883edca17a1a026 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-075 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-00 |
| filingDate |
2008-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9178ae25801d983c462f6abffaef5f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_830f62af7295528bda6383078bd12c86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_742e9cad46cc17ed9f4e17feb1b4c108 |
| publicationDate |
2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8486927-B2 |
| titleOfInvention |
Crystalline forms of lamotrigine |
| abstract |
The invention is directed to novel crystalline forms of lamotrigine. These novel crystalline forms of lamotrigine have improved dissolution and in-vivo absorption profile, as compared to pure lamotrigine. These novel crystalline forms of lamotrigine provide a substantial increase in the blood concentration of lamotrigine, as compared to pure lamotrigine when administered to a subject. These novel crystalline forms of lamotrigine also provide a slower, steady build up of lamotrigine blood concentration suitable for sustained release of lamotrigine in-vivo, as compared to pure lamotrigine. |
| priorityDate |
2007-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |